Compare AGM & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGM | ATRC |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | AGM | ATRC |
|---|---|---|
| Price | $174.36 | $39.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $219.00 | $52.22 |
| AVG Volume (30 Days) | 99.8K | ★ 469.6K |
| Earning Date | 02-20-2026 | 02-11-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 12.85 | N/A |
| EPS | ★ 17.55 | N/A |
| Revenue | $377,946,000.00 | ★ $518,304,999.00 |
| Revenue This Year | $14.80 | $16.94 |
| Revenue Next Year | $9.98 | $12.54 |
| P/E Ratio | $9.94 | ★ N/A |
| Revenue Growth | 8.81 | ★ 15.80 |
| 52 Week Low | $155.00 | $28.29 |
| 52 Week High | $212.24 | $43.18 |
| Indicator | AGM | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 51.04 |
| Support Level | $168.35 | $37.98 |
| Resistance Level | $177.99 | $41.80 |
| Average True Range (ATR) | 4.50 | 2.03 |
| MACD | -0.19 | -0.22 |
| Stochastic Oscillator | 67.72 | 51.54 |
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.